Evidence map›Paper›PMID 29544191›Full record

ArticlePsychoneuroendocrinology2018

Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors.

Laura J Mosher, Sean C Godar, Marc Morissette, Kenneth M McFarlin, Simona Scheggi, Carla Gambarana, Stephen C Fowler, Thérèse Di Paolo, Marco Bortolato

Abstract read
In one paragraph

Article in Psychoneuroendocrinology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Control of social status by sex steroids: insights from teleost fishes.Molecular psychology : brain, behavior, and society · 2023
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Laura J MosherDept of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, United States; Dept of Pharmacology and Toxicology, School of Pharmacy, University of Kansas, Lawrence, KS, United States.
Sean C GodarDept of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, United States.
Marc MorissetteNeuroscience Research Unit, Centre Hospitalier Universitaire de Québec, CHUL, Quebec City, Quebec, Canada.
Kenneth M McFarlinDept of Pharmacology and Toxicology, School of Pharmacy, University of Kansas, Lawrence, KS, United States. Electronic address: kennethmcfarlin@ku.edu.
Simona ScheggiDept of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, United States; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
Carla GambaranaDepartment of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
Stephen C FowlerDept of Pharmacology and Toxicology, School of Pharmacy, University of Kansas, Lawrence, KS, United States.
Thérèse Di PaoloNeuroscience Research Unit, Centre Hospitalier Universitaire de Québec, CHUL, Quebec City, Quebec, Canada; Faculty of Pharmacy, Laval University, Quebec City, Quebec, Canada.
Marco BortolatoDept of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, United States. Electronic address: marco.bortolato@utah.edu.

Funding

Deciphering gene-environment interactions in pathological reactive aggressionR01MH104603 · NIMH · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Marco Bortolato, Regina A. Mangieri · 2014 to 2026
$6.0M
Interactions of MAO A with vulnerability factors for aggressionR21HD070611 · NICHD · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BORTOLATO, MARCO · 2011 to 2012
$434k
Elucidating the Role of Neuroactive Steroids in Tourette SyndromeF31NS093939 · NINDS · UNIVERSITY OF KANSAS LAWRENCE · PI MOSHER, LAURA · 2016 to 2017
$57k
NICHD NIH HHS R21 HD070611NIMH NIH HHS R01 MH104603NINDS NIH HHS F31 NS093939
6 · The paper itself

Abstract

The enzyme steroid 5α-reductase 2 (5αR2) catalyzes the conversion of testosterone into the potent androgen 5α-dihydrotestosterone. Previous investigations showed that 5αR2 is expressed in key brain areas for emotional and socio-affective reactivity, yet the role of this enzyme in behavioral regulation remains mostly unknown. Here, we profiled the behavioral characteristics of 5αR2 heterozygous (HZ) and knockout (KO) mice, as compared with their wild-type (WT) littermates. While male 5αR2 KO mice displayed no overt alterations in motoric, sensory, information-processing and anxiety-related behaviors, they exhibited deficits in neurobehavioral correlates of dominance (including aggression against intruders, mating, and tube dominance) as well as novelty-seeking and risk-taking responses. Furthermore, male 5αR2 KO mice exhibited reduced D

Indexed as

3-Oxo-5-alpha-Steroid 4-DehydrogenaseAndrogensAnimalsBehavior, AnimalDihydrotestosteroneDisorder of Sex Development, 46,XYDisruptive, Impulse Control, and Conduct DisordersExploratory BehaviorHypospadiasMaleMiceMice, KnockoutSocial DominanceSteroid Metabolism, Inborn ErrorsTestosterone3-Oxo-5-alpha-Steroid 4-DehydrogenaseAndrogensDihydrotestosteroneTestosterone5α-reductaseAggressionDominanceDopamineNovelty seekingRisk takingTransgenic mice

Identifiers

PMID29544191
PMCPMC5901899

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.